 Primary endpoint: To determine the effects of vitamin D supplementation at two doses a 5,000 IU daily b 10,000 IU daily compared to c placebo a 24 weeks period on the change from baseline in frequency of CD4 T cell subsets and cytokine responses by peripheral blood mononuclear cells in 1 patients with the clinically isolated syndrome. 2 healthy control participants. 